Press Releases
Genetix Presents Recent Patient Experience Data from U.S. Commercial Gene Therapy Implementation at the 67th American Society of Hematology (ASH) Annual Meeting
At the American Society of Hematology (ASH) Annual Meeting, Genetix shares new real-world commercial demonstrating the value proposition of one-time, durable gene therapy.
Read moreGenetix Participates in the American Society of Hematology’s (ASH) Exclusive Press Program & Shares Recent Patient Experience Data from U.S. Commercial Gene Therapy Implementation
Selected for ASH’s exclusive press program, Genetix presents real-world data showing rising adoption and faster access for its one-time gene therapies.
Read moreGenetix Biotherapeutics to Present Recent Patient Experience Data from U.S. Commercial Gene Therapy Implementation at the 67th American Society of Hematology (ASH) Annual Meeting
Genetix will be presenting real-world data on access, coverage, and the patient journey in sickle cell disease and transfusion-dependent beta-thalassemia at the 67th American Society of Hematology Annual Meeting.
Read morebluebird bio Rebrands to Genetix Biotherapeutics, Returning to Its Foundational Roots
Read the full rebrand story of why we became Genetix Biotherapeutics, returning to our foundational roots and renewing our commitment to delivering transformative genetic therapies.
Read more